Citalopram pharmacokinetics in patients with chronic renal failure and the effect of haemodialysis

Author： Spigset Olav   Hägg Staffan   Stegmayr Bernd   Dahlqvist Rune  

Publisher： Springer Publishing Company

ISSN： 0031-6970

Source： European Journal of Clinical Pharmacology, Vol.56, Iss.9-10, 2000-12, pp. : 699-703

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Effect of Severe Renal Failure and Haemodialysis on the Pharmacokinetics of Levosimendan and Its Metabolites

By Puttonen Jaakko  

Clinical Pharmacokinetics, Vol. 46, Iss. 3, 2007-01 ,pp. : 235-246

Adis International

Access to resources Recommend Favorite

Effect of Impaired Renal Function and Haemodialysis on the Pharmacokinetics of Aprepitant

By Bergman Arthur J.  

Clinical Pharmacokinetics, Vol. 44, Iss. 6, 2005-01 ,pp. : 637-647

Adis International

Access to resources Recommend Favorite

Pharmacokinetics and Lipid-lowering Effect of Fluvastatin in Hypercholesterolaemic Patients on Maintenance Haemodialysis

By Ichimaru N   Takahara S   Moriyama T   Kondo M   Nonomura N   Tanaka T   Wang J-D   Imai E   Okuyama A   Kondo Y  

The Journal of International Medical Research, Vol. 32, Iss. 1, 2004-01 ,pp. : 45-52

Field House Publishing

Access to resources Recommend Favorite

Pharmacokinetics of Meropenem in Patients with Renal Failure and Patients Receiving Renal Replacement Therapy

By Thalhammer F.  

Clinical Pharmacokinetics, Vol. 39, Iss. 4, 2000-10 ,pp. : 271-279

Adis International

Access to resources Recommend Favorite

Effects of Chronic Renal Failure on the Pharmacokinetics of Ruboxistaurin and its Active Metabolite 338522

By Wise Stephen  

Clinical Pharmacokinetics, Vol. 45, Iss. 3, 2006-01 ,pp. : 297-303

Adis International

Access to resources Recommend Favorite